16 research outputs found
Target 2035 - an update on private sector contributions
Get PDFTarget 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging ‘open’ principles to develop a pharmacological tool for every human protein. These tools are important reagents for scientists studying human health and disease and will facilitate the development of new medicines. It is therefore not surprising that pharmaceutical companies are joining Target 2035, contributing both knowledge and reagents to study novel proteins. Here, we present a brief progress update on Target 2035 and highlight some of industry's contributions
Target 2035 - an update on private sector contributions
Get PDFTarget 2035, an international federation of biomedical scientists from the public and private sectors, is leveraging ‘open’ principles to develop a pharmacological tool for every human protein. These tools are important reagents for scientists studying human health and disease and will facilitate the development of new medicines. It is therefore not surprising that pharmaceutical companies are joining Target 2035, contributing both knowledge and reagents to study novel proteins. Here, we present a brief progress update on Target 2035 and highlight some of industry's contributions
Analyse der Einflussfaktoren auf das Reha-Ergebnis bei Patienten mit degenerativen Wirbelsäulenerkrankungen unter Berücksichtigung unterschiedlicher Schweregradgruppen
No full textRehabilitationsprozess und -verlauf bei Knie-TEP-Rehabilitanden in Abhängigkeit des Schweregrades und der Behandlungsdauer
No full text
Motivation and Participation in a Phase III Cardiac Rehabilitation Programme: An Application of the Health Action Process Approach
No full text
